Social Media Monitoring und Social Response Management

Umfassende Lösungen für regulatorische Anforderungen im Bereich Social Media.

Erfahrungen und Kompetenzen im Bereich Community Management

Webinar icon

Maßgeschneiderte Community-Management-Services

Dienstleistungen, die individuell auf Ihre Bedürfnisse zugeschnitten sind.

Maßgeschneiderte Community-Management-Services

Dienstleistungen, die individuell auf Ihre Bedürfnisse zugeschnitten sind.

Weniger lesen
Around the world icon

Multilinguale Services

35+ Sprachen

Multilinguale Services

35+ Sprachen

Weniger lesen
Authority Meetings icon

Hochqualifizierte Expert*innen

Unser Team ist auf AE‑ und PQC‑Berichterstattung spezialisiert und steht für exzellenten Service.

Hochqualifizierte Expert*innen

Unser Team ist auf AE‑ und PQC‑Berichterstattung spezialisiert und steht für exzellenten Service.

Weniger lesen
Global icon

Globales Serviceangebot

Wir bieten Erfahrungen mit Community-Management-Services auf der ganzen Welt unter Einhaltung der Vorschriften verschiedener Aufsichtsbehörden.

Globales Serviceangebot

Wir bieten Erfahrungen mit Community-Management-Services auf der ganzen Welt unter Einhaltung der Vorschriften verschiedener Aufsichtsbehörden.

Weniger lesen
Social media icon

Kompetenzen mit verschiedenen Plattformen

Facebook, Instagram, LinkedIn, X und mehr.

Kompetenzen mit verschiedenen Plattformen

Facebook, Instagram, LinkedIn, X und mehr.

Weniger lesen

Social Media Monitoring Services

ProPharma überwacht sorgfältig die Social-Media-Kanäle unserer Kund*innen und achtet dabei auf auftretende unerwünschte Ereignisse oder Produktbeschwerden. Sobald wir etwas Meldepflichtiges entdecken, dokumentieren wir es umgehend und melden es innerhalb der vorgeschriebenen Frist, um sicherzustellen, dass keine wichtigen Informationen verloren gehen.

Social Response Management

ProPharma geht aktiv auf Kommentare und Anfragen von Verbrauchern auf verschiedenen Social-Media-Plattformen ein und agiert dabei in Ihrem Namen. Wir verwenden von Kund*innen genehmigte standardisierte Antworten, die speziell auf diese Interaktionen zugeschnitten sind. Ob wir öffentlich auf Kommentare unter Beiträgen oder privat über Direktnachrichten antworten, ProPharma stellt sicher, dass jede Interaktion professionell, angemessen und nicht werblich ist. Mit diesem Service entfernt ProPharma auch unangemessene Kommentare aus Ihren Beiträgen, um das professionelle Image Ihres Unternehmens zu wahren.

Business professionals smiling at a desk reviewing data
Gradient Image

Kontaktieren Sie uns zu unserer Expertise im Bereich Community-Management Service

Wir haben es uns zur Aufgabe gemacht, die Gesundheit und das Wohlbefinden der Verbraucherinnen durch umfassendes Community-Management zu verbessern. Ganz gleich, ob Sie zuverlässige Social-Media-Monitoring-Dienstleistungen oder einen Komplettservice einschließlich Social Response Management benötigen, unser Expert*innenteam steht Ihnen gerne zur Verfügung.

News & Insights

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

Oktober 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture

September 28, 2026

Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture

Explore how inspection readiness is evolving in the pharmaceutical industry, emphasizing continuous compliance, quality culture, and global regulatory expectations.

Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and Market Opportunities

August 24, 2026

Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and ...

Explore the complex regulatory landscape of Eastern Europe for marketing authorization, and discover strategic opportunities for market entry and growth.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

Juli 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

Juni 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

Januar 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Recognized for AI Excellence at ECCCSA

Januar 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

Oktober 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

Juli 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Dezember 2, 2026

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Oktober 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

News & Insights

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture

September 28, 2026

Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture

Explore how inspection readiness is evolving in the pharmaceutical industry, emphasizing continuous compliance, quality culture, and global regulatory expectations.

Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and Market Opportunities

August 24, 2026

Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and ...

Explore the complex regulatory landscape of Eastern Europe for marketing authorization, and discover strategic opportunities for market entry and growth.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

Juli 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Previous Resource Arrow Next Resource Arrow
Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Dezember 2, 2026

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Oktober 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

Previous Webinar Arrow Next Webinar Arrow